Report Description Table of Contents Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Treatments by Wound Type, Product & End-User The global negative pressure wound therapy market will witness a robust CAGR of 5.7%, valued at $2.37 billion in 2021, expected to appreciate and reach $3.92 billion by 2030, confirms Strategic Market Research. North America held the highest share of the industry, reaching a landmark of up to USD 702 Mn. Negative Wound Pressure Therapy refers to a medical procedure where sub-atmospheric pressures are applied to a wound to assist it in healing. It is also known as vacuum-assisted closure therapy. A subatomic pressure of 125 mmHg below ambient pressure is applied to a wound bed through a suction device attached to a sponge. The closed suction removes the excess fluid from the wound, which allows for enhanced circulation, reduced risk of contamination, and removal of cellular waste. NPWT manages wounds that are too large or cannot be addressed through conventional methods. The dressing can be changed every 48 to 72 hours, but for untreated wounds, it must be changed in every 12 hours. NPWT assists in removing edema, reducing microbial bio-burden, increasing blood circulation, increasing granulation tissue formation, and providing a moist wound-healing atmosphere. A new application of NPWT suggests that it could be applied to closed surgical wounds, especially on closed orthopedic incisional (COI) wounds. Applying NPWT to a COI wound decreases the prevalence of surgical wound-healing complications, and the wound healing speeds up. It is a popular method to treat many acute and chronic wounds, which are caused mostly due to chronic diseases. Chronic diseases are expected to rise as the CIHR (Canadian Institute of Health Research claims that 8.8% of the Canadian population has been diagnosed with diabetes & 6.1% of Canadian adults are at high risk of developing diabetes, thereby boosting the industry growth. Drivers - Increasing Number of Chronic Wounds, Introduction of Technologically Advanced NPWT Devices, Increased Success Rate of NPWT The increase in chronic wounds suffered by people worldwide is a significant factor contributing to the rise in the negative pressure wound therapy market size. According to a study by NCBI, around 2% of the USA’s total population suffers from chronic wounds. Chronic wounds mainly occur along with chronic diseases. Along with an increasing number of chronic wounds suffered by the population, new and improved harmful pressure wound therapy devices and methods have also helped improve the market growth. Procedures like the wound VAC therapy, VAC dressing pressure, and negative pressure therapy have created the need and use of negative pressure wound therapy devices such as PICO VAC dressing, negative pressure pump, wound pump, portable wound VAC, NPWT wound VAC, Smith Nephew PICO 7, Medela Wound VAC, negative pressure dressing, wound VAC dressing, NPWT dressing and the PICO wound VAC to treat chronic wounds. The higher success rate of NPWT over conventional therapy caused the demand for the treatment procedure to rise, which in turn surged the overall NPWT market growth. According to a study conducted by the NCBI, the success rate of NPWT for treating diabetic foot wounds was 90%, as compared to 76.6% with conventional treatment. Restraints - High Cost of NPWT over Conventional Therapy, Limited Number of Trained Professionals The price of NPWT was observed to be more than that of conventional therapy. For example, a study by BioMedCentral found that the cost per patient treated with NPWT is $142 more than the cost per patient treated using conventional methods. The number of medical professionals trained in NPWT techniques and devices is less, thus hindering the treatment of patients requiring such procedures. Opportunities - Advancement in Technologies, Use of Portable and Disposable Models The enhancement of technologies in NPWT enables patients to have their wounds healed faster. While installing the technology costs a lot, the actual therapy is cost-efficient. This presents a genuine growth opportunity in this negative pressure wound therapy market. The use of portable and disposable NPWT models in homecare settings safeguards patients' safety from reinfections that could lead to possible amputations. In addition, it eliminates the hospital stay costs and allows the patient to enjoy a sense of comfort at his home. According to a study, NPWT dressing for home care starts at around USD 90. Thus, the governmental bodies are emphasizing the enhancement in the production of these NPWT models, which will cater to significant market opportunities in the course of time. Negative Pressure Wound Therapy Market Analysis Of Different Segments Covered in the Report Based on Product Single-use NPWT device Conventional NPWT device NPWT accessories Based on Wound Type Chronic Wounds Acute Wounds Based on End-User Hospitals and Clinics Home Care Regional Coverage Analysis North America United States of America Canada Mexico Europe Germany France United Kingdom Italy Rest of Europe Asia-Pacific Japan China India Rest of Asia-Pacific LAMEA Brazil Saudi Arabia South Africa Rest of LAMEA Segments Analysis & Insights Based on the Product, the ‘Conventional NPWT device accounted for the largest market share in 2019, with a CAGR of 5.5%. This is attributed to a reduction in the overall cost of treatment due to decreased length of stay and better management of severe wounds. According to a study by the NCBI, the average length of stay for NPWT was 9.7 days compared to 11.2 days for conventional treatment. Based on Wound type, the ‘Chronic Wound segment accounted for the largest market size in 2019, with a CAGR of around 6%. This is because chronic diseases among people are expected to surge, which could cause chronic wounds. According to the NCBI, chronic wounds affect 6.5 million people in the US. Based on End-users, the Hospitals segment held the largest market share in 2018, accounting for USD 597.5 million. This can be attributed to increased patient influx for acute and chronic wound treatment and the infection rate due to surgical wounds. Studies have shown that the infection rate for surgical wounds ranges from 8% among the general population to 25% in people over 60 years old. The Home Care segment has the fastest-growing CAGR in the NPWT market. Increased frequency of age-related diseases, increased sales of disposables and single-use goods, and growing healthcare expenses have driven the growth of this segment. Based on Region, North America had the largest share of the market in 2018, accounting for up to USD 702 million. The introduction of low-cost NPWT technology, the rising geriatric population, and increasing cases of chronic wounds caused the market to grow significantly in this region. According to the Agency for Healthcare Research and Quality, more than 2.5 million people suffer from pressure ulcers in the US. However, the Asia-Pacific region held the fastest CAGR during the forecast period. The rapid increase in chronic wounds due to chronic diseases in this region and technological advances in NPWT devices are the primary reasons that are significantly fostering market growth. According to the International Diabetes Federation, around 1.07 billion people aged 20 to 79 years suffer from diabetes in China. Negative Pressure Wound Therapy Market Report Coverage Report Attribute Details Forecast Period 2021 - 2030 The market size value in 2021 USD 2.37 Billion The revenue forecast in 2030 USD 3.92 billion Growth rate CAGR of approximately 5.7% The base year for estimation 2021 Historical data 2017 – 2020 Unit USD Billion, CAGR (2021 - 2030) Segmentation By Product, By Wound Type, By End-user, and By Region. By Type Single-use NPWT device, Conventional NPWT device, NPWT accessories By Wound Type Chronic Wounds, Acute Wounds By End-User Hospitals and Clinics, Home Care By Region Asia Pacific, North America, Europe, LAMEA Country Scope United States of America, Mexico, Germany, France, United Kingdom, Italy, Canada, Japan, China, India, Brazil, Saudi Arabia, South Africa Company Usability Profiles Smith & Nephew, ConvaTec Inc., Cardinal Health, Medela AG, Mölnlycke Health Care AB, Talley Group Ltd., PAUL HARTMANN Asia-Pacific Ltd., Lohmann and Rauscher GmbH & Co. KG, 3M Acelity L.P. Inc. Negative Pressure Wound Therapy Market Competitive Landscape Analysis The competitive landscape analysis provides key information about the competitors aiming to obtain a sizable share in the market. The competitors are analyzed based on their brand image, strong distribution network in first-world countries, and diverse offerings. Smith & Nephew ConvaTec Inc. Cardinal Health Medela AG Mölnlycke Health Care AB Talley Group Ltd. PAUL HARTMANN Asia-Pacific Ltd. Lohmann and Rauscher GmbH & Co. KG 3M Acelity L.P. Inc. Recent Developments On August 2022, 3M, one of the global leaders of the healthcare industry, upgraded its NPWT process by introducing some installation techniques for the clinicians to carry out their operations successfully. The brand new Veraflo Dressing Kit and V.A.C. Ulta-Therapy Units were introduced. These brand new offerings by the organization will help ease the care-delivery process of the clinicians by using the Veraflo NPWT technique and will make the dressing process much faster, easier, & less painful for the patients. In March 2022, Cardinal Health announced the first surgical incise drape launch using chlorhexidine gluconate (CHG). Cardinal Health believes this new drape can improve patient care by reducing the risk of microbial contamination. In January 2022, Smith & Nephew announced new uses for PICO 7 & PICO 14 single-use negative pressure wound therapy systems. The US FDA announced the clearance of the product to be used on closed surgical incisions to reduce Superficial and deep incisional surgical site infections (SSIs) for high-risk patients in Class I & Class II wounds, Post-operative Seroma, and Dehiscence. In January 2022, ConvaTec Group PLC announced the acquisition of Triad Life Sciences, Inc. ConvaTec believes that it would allow them to subsume the wound biologics segment. In November 2021, Medela LLC announced the release of new data that suggests that the Medela Invia Liberty Negative Pressure Wound Therapy System outperforms other multi-lumen NPWT systems available in the market. The data demonstrated how Medela’s Invia Liberty NPWT system could clear 89% of the fluid bolus challenge and re-establish prescribed pressure within 20 minutes. In March 2021, Direct Healthcare Group announced the acquisition of Talley Group Ltd. The acquisition will allow Direct Healthcare Group entry into the Negative Pressure Wound Therapy and Intermittent Pneumatic Compression Therapy markets. List of Devices that Key Market Leaders Develop Product Function Key Players ACTICOAT Infection management of wounds Smith & Nephew ABTHERA Open Abdomen Negative Pressure Therapy Temporary abdominal closure system 3M Acelity L.P., Inc. Avelle NPWT System Maintaining an optimal environment for wound healing while undergoing NPWT ConvaTec, Inc. ALLY Therapy System Simplifies NPWT for patient Cardinal Health Invia Liberty NPWT System Treatment of a variety of wounds in all patient care settings Medela AG Frequently Asked Question About This Report What is the most dominant region in the global market? The dominant region in the global market is North America. What is the negative pressure wound therapy market growth? The global negative pressure wound therapy market is expected to grow at a compound annual growth rate (CAGR) of 5.7% from 2021 to 2030 to reach USD 3.92 Billion by 2030. Which is the most dominant product type in the global market? Based on the Product, the Conventional NPWT device accounted for the largest market share in 2019, with a CAGR of 5.5%. How big is this negative pressure wound therapy market size ? The global negative pressure wound therapy market size was $2.37 Bn in 2021 and is predicted to reach $3.92 Bn by 2030, representing a CAGR of 5.7%. Which region held the maximum share of the global market? North America had the largest share of the market in 2018, accounting for up to USD 702 million. Sources https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6739293/ https://www.canada.ca/en/institutes-health-research/news/2021/08/government-of-canada-announces-new-investment-in-diabetes-research.html https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6389759/ https://wjes.biomedcentral.com/articles/10.1186/s13017-022-00415-1 https://www.hca.wa.gov/assets/program/npwt-final-report-20161012.pdf 1. Introduction 1.1. Study Objective 1.2. Market Definition 1.3. Study Scope 1.3.1. Markets Covered 1.3.2. Geographic Scope 1.3.3. Years Considered 1.3.4. Stakeholders 2. Research Methodology 2.1. Data Procurement 2.2. Paid Database 2.2.1. Secondary Data 2.2.1.1. Key Secondary sources 2.2.2. Primary Data 2.2.2.1 Primary sources 2.2.2.2. Key industry insights 2.2.2.3. Primary interviews with experts 2.2.2.4. Key primary respondent list 2.3. Market Size Estimation 2.4. Bottom-Up and Top-Down Approaches 2.4.1. Bottom-Up Approach 2.4.1.1. Approach for arriving at market size by bottom-up analysis 2.4.2. Top-Down Approach 2.4.2.1. Approach for Capturing Market Size by Top-Down Analysis 2.5. Market Breakdown and Data Triangulation 2.6. Research Methodology 2.7. Risk Assessment 3. Executive Summary 3.1 Market: Post-Covid-19 3.1.1 Actual Scenario 3.1.2 Pessimistic Scenario 3.1.3 Optimistic Scenario 3.1.4 Market Summary 4. Industry Outlook 4.1 Market Snapshot 4.2 Global Negative Pressure Wound Therapy Market 4.2.1 Global Market, 2021 – 2030 (USD Million) 4.3 Regional Business Analysis 4.3.1 Global Market, by region, 2021 - 2030 (USD Million) 4.4 By Product Analysis 4.4.1 Global Market, By Product, 2021 - 2030 (USD Million) 4.5 By End-User Analysis 4.5.1 Global Market, By End-User, 2021 - 2030 (USD Million) 4.6 Wound Type Analysis 4.6.1 Global Market, By Wound Type, 2021 - 2030 (USD Million) 4.7 Value Chain Analysis 4.8 Market Variable Analysis 4.8.1 Market Drivers Analysis 4.8.2 Market Restraints Analysis 4.9Business Environment Analysis Tool 4.9.1 Market PEST analysis 4.9.2 Market Porter’s analysis 4.10Penetration & Growth Prospect Mapping 5. Market Dynamics 5.1. Introduction 5.2. Market Dynamics 5.2.1. Drivers 5.2.2. Restraints 5.2.3. Opportunities 5.2.4. Challenges 5.3. Impact of Covid-19 On Market 5.4. Value Chain Analysis 5.5. Ecosystem 5.6. Patent Analysis 5.7. Trade Analysis 5.8. Tariff Analysis 5.9. Case Study Analysis 5.10. Porter’s Five Forces Analysis 5.10.1 Threat of New Entrants 5.10.2 Threat of Substitutes 5.10.3 Bargaining Power of Buyers 5.10.4 Bargaining Power of Suppliers 5.10.5 Degree of Competition 5.11. Wound Type Analysis 5.11.1. Trends in Wound Type (2014-2020) 5.11.2. Trends in Wound Type (2021-2028) 5.12. Pricing Analysis 5.12.1. Average Price Trend Analysis (By region, By Countries) 6. Competitive & Vendor Landscape 6.1. Company Market Share Analysis 6.2. Manufacturers Negative Pressure Wound Therapy Manufacturing Sites, Area Served, Product Product 6.3. Market Competitive Situation and Trends 6.4. Manufacturers Mergers & Acquisitions, Expansion Plans 7. Global Market: By Product Segment Analysis 7.1. Introduction 7.2. Sales Volume & Revenue Analysis (2021-2030) 7.3. Single-use NPWT device 7.3.1. Single-use NPWT device market, 2021 - 2030 (USD Million) 7.4. Conventional NPWT device 7.4.1. Conventional NPWT device market, 2021 - 2030 (USD Million) 7.5. NPWT accessories 7.5.1. NPWT accessories market, 2021 - 2030 (USD Million) 8. Global Market: By End-User Segment Analysis 8.1. Introduction 8.2. Sales Volume & Revenue Analysis (2021-2030) 8.3. Hospitals and Clinics 8.3.1. Hospitals and Clinics market, 2021 - 2030 (USD Million) 8.4. Home Care 8.4.1. Home Care market, 2021 - 2030 (USD Million) 9. Global Market: By Wound Type Segment Analysis 9.1. Introduction 9.2. Sales Volume & Revenue Analysis (2021-2030) 9.3. Chronic Wounds 9.3.1. Chronic Wounds market, 2021 - 2030 (USD Million) 9.4. Acute Wounds 9.4.1. Acute Wounds market, 2021 - 2030 (USD Million) 10. Global Market: Regional Outlook 10.1 North America 10.1.1. North America Market, By Product, 2021 - 2030 (USD Million) 10.1.2. North AmericaMarket, By End-User, 2021 - 2030 (USD Million) 10.1.3. North America Market, by Wound Type, 2021 - 2030 (USD Million) 10.1.4. North America Market, by Country, 2021 - 2030 (USD Million) 10.1.4.1. U.S. 10.1.4.1.1. U.S. Market, By Product, 2021 - 2030 (USD Million) 10.1.4.1.2. U.S. Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.1.3. U.S. Market, by Wound Type, 2021 - 2030 (USD Million) 10.1.4.2.Canada 10.1.4.2.1. Canada Market, By Product, 2021 - 2030 (USD Million) 10.1.4.2.2. Canada Market, By End-User, 2021 - 2030 (USD Million) 10.1.4.2.3. Canada Market, by Wound Type, 2021 - 2030 (USD Million) 10.2. Europe 10.2.1. Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.2. Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.3. Europe Market, by Wound Type, 2021 - 2030 (USD Million) 10.2.4. Europe Market, by country, 2021 - 2030 (USD Million) 10.2.4.1 U.K. 10.2.4.1.1. U.K. Market, By Product, 2021 - 2030 (USD Million) 10.2.4.1.2. U.K. Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.1.3. U.K. Market, by Wound Type, 2021 - 2030 (USD Million) 10.2.4.2. Germany 10.2.4.2.1. Germany Market, By Product, 2021 - 2030 (USD Million) 10.2.4.2.2. Germany Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.2.3. Germany Market, by Wound Type, 2021 - 2030 (USD Million) 10.2.4.3. France 10.2.4.3.1. France Market, By Product, 2021 - 2030 (USD Million) 10.2.4.3.2. France Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.3.3. France Market, by Wound Type, 2021 - 2030 (USD Million) 10.2.4.4. Rest of Europe 10.2.4.4.1. Rest of Europe Market, By Product, 2021 - 2030 (USD Million) 10.2.4.4.2. Rest of Europe Market, By End-User, 2021 - 2030 (USD Million) 10.2.4.4.3. Rest of Europe Market, by Wound Type, 2021 - 2030 (USD Million) 10.3. Asia Pacific 10.3.1. Asia Pacific Market, By Product, 2021 - 2030 (USD Million) 10.3.2. Asia Pacific Market, By End-User, 2021 - 2030 (USD Million) 10.3.3. Asia Pacific Market, by Wound Type, 2021 - 2030 (USD Million) 10.3.4. Asia Pacific Market, by country, 2021 - 2030 (USD Million) 10.3.4.1. China 10.3.4.1.1. China Market, By Product, 2021 - 2030 (USD Million) 10.3.4.1.2. China Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.1.3. China Market, by Wound Type, 2021 - 2030 (USD Million) 10.3.4.2. India 10.3.4.2.1. India Market, By Product, 2021 - 2030 (USD Million) 10.3.4.2.2. India Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.2.3. IndiaMarket, by Wound Type, 2021 - 2030 (USD Million) 10.3.4.3. Japan 10.3.4.3.1. JapanMarket, By Product, 2021 - 2030 (USD Million) 10.3.4.3.2. JapanMarket, By End-User, 2021 - 2030 (USD Million) 10.3.4.3.3. Japan Market, by Wound Type, 2021 - 2030 (USD Million) 10.3.4.4. South Korea 10.3.4.4.1. South Korea Market, By Product, 2021 - 2030 (USD Million) 10.3.4.4.2. South Korea Market, By End-User, 2021 - 2030 (USD Million) 10.3.4.4.3. South Korea Market, by Wound Type, 2021 - 2030 (USD Million) 10.3.4.5. Rest of ASIA PACIFIC 10.3.4.5.1. Rest of ASIA PACIFICMarket, By Product, 2021 - 2030 (USD Million) 10.3.4.5.2. Rest of ASIA PACIFICMarket, By End-User, 2021 - 2030 (USD Million) 10.3.4.5.3. Rest of ASIA PACIFICMarket, by Wound Type, 2021 - 2030 (USD Million) 10.4. Latin America 10.4.1. Latin America Market, By Product, 2021 - 2030 (USD Million) 10.4.2. Latin America Market, By End-User, 2021 - 2030 (USD Million) 10.4.3. Latin America Market, by Wound Type, 2021 - 2030 (USD Million) 10.4.4. Latin America Market, by country, 2021 - 2030 (USD Million) 10.4.4.1. Brazil 10.4.4.1.1. Brazil Market, By Product, 2021 - 2030 (USD Million) 10.4.4.1.2. Brazil Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.1.3. Brazil Market, by Wound Type, 2021 - 2030 (USD Million) 10.4.4.2. Mexico 10.4.4.2.1. Mexico Market, By Product, 2021 - 2030 (USD Million) 10.4.4.2.2. Mexico Market, By End-User, 2021 - 2030 (USD Million) 10.4.4.2.3. Mexico Market, by Wound Type, 2021 - 2030 (USD Million) 10.4.4.3. Rest of the Latin America 10.4.4.3.1. Rest of the Latin AmericaMarket, By Product, 2021 - 2030 (USD Million) 10.4.4.3.2. Rest of the Latin AmericaMarket, By End-User, 2021 - 2030 (USD Million) 10.4.4.3.3. Rest of the Latin AmericaMarket, by Wound Type, 2021 - 2030 (USD Million) 10.5. MEA 10.5.1. MEA Market, By Product, 2021 - 2030 (USD Million) 10.5.2. MEA Market, By End-User, 2021 - 2030 (USD Million) 10.5.3. MEA Market, by Wound Type, 2021 - 2030 (USD Million) 10.5.4. MEA Market, by Region, 2021 - 2030 (USD Million) 11. Competitive Landscape 11.1 Smith & Nephew 11.1.1. Company overview 11.1.2. Financial performance 11.1.3. ProductPortfolio Analysis 11.1.4. Business Strategy & Recent Development 11.2. KCI LICENSING, INC 11.2.1. Company overview 11.2.2. Financial performance 11.2.3. Product Portfolio Analysis 11.2.4. Business Strategy & Recent Development 11.3. CONVATEC INC 11.3.1. Company overview 11.3.2. Financial performance 11.3.3. Product Portfolio Analysis 11.3.4. Business Strategy & Recent Development 11.4. CARDINAL HEALTH 11.4.1. Company overview 11.4.2. Financial performance 11.4.3. Product Portfolio Analysis 11.4.4. Business Strategy & Recent Development 11.5. MEDELA AG 11.5.1. Company overview 11.5.2. Financial performance 11.5.3. Product Portfolio Analysis 11.5.4. Business Strategy & Recent Development 11.6. Mölnlycke Health Care AB 11.6.1. Company overview 11.6.2. Financial performance 11.6.3. Product Portfolio Analysis 11.6.4. Business Strategy & Recent Development 11.7. Talley Group Ltd 11.7.1. Company overview 11.7.2. Financial performance 11.7.3. Product Portfolio Analysis 11.7.4. Business Strategy & Recent Development 11.8. PAUL HARTMANN Asia-Pacific Ltd. 11.8.1. Company overview 11.8.2. Financial performance 11.8.3. Product Portfolio Analysis 11.8.4. Business Strategy & Recent Development 11.9. Lohmann and Rauscher GmbH & Co. KG 11.9.1. Company overview 11.9.2. Financial performance 11.9.3. Product Portfolio Analysis 11.9.4. Business Strategy & Recent Development 11.10. 3M Acelity L.P. Inc 11.10.1. Company overview 11.10.2. Financial performance 11.10.3. Product Portfolio Analysis 11.10.4. Business Strategy & Recent Development List of Tables (47 Tables) TABLE 1. Market, By Product, 2021-2030 (USD Million) TABLE 2. Market FOR Single-use NPWT device, BY REGION, 2021-2030 (USD Million) TABLE 3. Market FOR Conventional NPWT device, BY REGION, 2021-2030 (USD Million) TABLE 4. Market FOR NPWT accessories, BY REGION, 2021-2030 (USD Million) TABLE 5. Market, By End-User, 2021-2030 (USD Million) TABLE 6. Market FOR Hospitals and Clinics, BY REGION, 2021-2030 (USD Million) TABLE 7. Market FOR Home Care, BY REGION, 2021-2030 (USD Million) TABLE 8. Market, BY WOUND TYPE, 2021-2030 (USD Million) TABLE 9. Market FOR Chronic Wounds, BY REGION, 2021-2030 (USD Million) TABLE 10. Market FOR Acute Wounds, BY REGION, 2021-2030 (USD Million) TABLE 11. Market, BY REGION, 2021-2030 (USD Million) TABLE 12. NORTH AMERICA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 13. NORTH AMERICA Market, By Product, 2021-2030 (USD Million) TABLE 14. NORTH AMERICA Market, By End-User, 2021-2030 (USD Million) TABLE 15. NORTH AMERICA Market, BY WOUND TYPE, 2021-2030 (USD Million) TABLE 16. EUROPE Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 17. EUROPE Market, By Product, 2021-2030 (USD Million) TABLE 18. EUROPE Market, By End-User, 2021-2030 (USD Million) TABLE 19. EUROPE Market, BY WOUND TYPE, 2021-2030 (USD Million) TABLE 20. ASIA-PACIFIC Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 21. ASIA-PACIFIC Market, By Product, 2021-2030 (USD Million) TABLE 22. ASIA-PACIFIC Market, By End-User, 2021-2030 (USD Million) TABLE 23. ASIA-PACIFIC Market, BY WOUND TYPE, 2021-2030 (USD Million) TABLE 24. LAMEA Market, BY COUNTRY, 2021-2030 (USD Million) TABLE 25. LAMEA Market, By Product, 2021-2030 (USD Million) TABLE 26. LAMEA Market, By End-User, 2021-2030 (USD Million) TABLE 27. LAMEA Market, BY WOUND TYPE, 2021-2030 (USD Million) TABLE 28. Smith & Nephew: COMPANY SNAPSHOT TABLE 29. Smith & Nephew: OPERATING SEGMENTS TABLE 30. KCI LICENSING, INC: COMPANY SNAPSHOT TABLE 31. KCI LICENSING, INC: OPERATING SEGMENTS TABLE 32. CONVATEC INC: COMPANY SNAPSHOT TABLE 33. CONVATEC INC: OPERATING SEGMENTS TABLE 34. CARDINAL HEALTH: COMPANY SNAPSHOT TABLE 35. CARDINAL HEALTH: OPERATING SEGMENTS TABLE 36. MEDELA AG: COMPANY SNAPSHOT TABLE 37. MEDELA AG: OPERATING SEGMENTS TABLE 38. Mölnlycke Health Care AB: COMPANY SNAPSHOT TABLE 39. Mölnlycke Health Care AB: OPERATING SEGMENTS TABLE 40. Talley Group Ltd: COMPANY SNAPSHOT TABLE 41. Talley Group Ltd: OPERATING SEGMENTS TABLE 42. PAUL HARTMANN Asia-Pacific Ltd: COMPANY SNAPSHOT TABLE 43. PAUL HARTMANN Asia-Pacific Ltd: OPERATING SEGMENTS TABLE 44. Lohmann and Rauscher GmbH & Co. KG: COMPANY SNAPSHOT TABLE 45. Lohmann and Rauscher GmbH & Co. KG: OPERATING SEGMENTS TABLE 46. 3M Acelity L.P. Inc: COMPANY SNAPSHOT TABLE 47. 3M Acelity L.P. Inc: OPERATING SEGMENTS List of Figures (20 Figures) Figure 1 Market: Research Methodology Steps Figure 2 Research Design Figure 3 Breakdown of Primaries: Market Figure 4 Top 10 Companies with Highest No. Of Patent in Last 9 Years Figure 5 No. Of Patents Granted Per Year, 2019–2020 Figure 6 Import Data for Negative Pressure Wound Therapy, By Country, 2016–2020 (USD Thousand) Figure 7 Export Data for Negative Pressure Wound Therapy, By Country, 2016–2020 (USD Thousand) Figure 8 Data Triangulation Methodology Figure 9 Market, By End-User, 2019 vs. 2025 (USD Million) Figure 10 Market Share, By Wound Type, 2019 vs. 2025 (USD Million) Figure 11 Market Share, By Product, 2019 vs. 2025 (USD Million) Figure 12 Geographical Snapshot of the Market Figure 13 Conventional NPWT device to Witness Higher CAGR in Market for Product Segment during Forecast Period. Figure 14 Chronic Wounds to Witness Higher CAGR in Market for Wound Type Segment during Forecast Period. Figure 15 Hospitals and Clinics to Witness Higher CAGR in Market for End-User Segment during Forecast Period. Figure 16 North America region Accounted for the Largest Share of the Market, By Regional Basis, in 2019 Figure 17 Market: Drivers, Restraints, Opportunities, and Challenges Figure 18 North America: Market Snapshot Figure 19 Asia Pacific: Market Snapshot Figure 20 Vendor Dive: Evaluation Overview